IP Verse

Safe Desmopressin Administration - EP3278809

The patent EP3278809 was granted to Allergan on Nov 20, 2019. The application was originally filed on Jun 15, 2010 under application number EP17168865A. The patent is currently recorded with a legal status of "Revoked".

EP3278809

ALLERGAN
Application Number
EP17168865A
Filing Date
Jun 15, 2010
Status
Revoked
May 20, 2022
Publication Date
Nov 20, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FERRINGAug 20, 2020ARNOLD & SIEDSMAADMISSIBLE

Patent Citations (40) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003232078
DESCRIPTIONUS3980631
DESCRIPTIONUS4148787
DESCRIPTIONUS4548922
DESCRIPTIONUS4746508
DESCRIPTIONUS4860738
DESCRIPTIONUS4944429
DESCRIPTIONUS5023252
DESCRIPTIONUS5112804
DESCRIPTIONUS5122383
DESCRIPTIONUS5154122
DESCRIPTIONUS5212199
DESCRIPTIONUS5227169
DESCRIPTIONUS5314694
DESCRIPTIONUS5719122
DESCRIPTIONUS5731303
DESCRIPTIONUS6321942
DESCRIPTIONUS6446839
DESCRIPTIONUS6705493
DESCRIPTIONUS6708846
DESCRIPTIONUS6772915
DESCRIPTIONUS7112561
DESCRIPTIONUS7182226
DESCRIPTIONUS7244703
DESCRIPTIONUS7335186
DESCRIPTIONUS7405203
OPPOSITIONUS6227413
OPPOSITIONUS7112561
OPPOSITIONUS7182226
OPPOSITIONUS7244703
OPPOSITIONUS7405203
OPPOSITIONUS9539302
OPPOSITIONWO2010075266
OPPOSITIONWO9501183
SEARCHUS2009005432
SEARCHUS2009035260
SEARCHUS5731303
SEARCHWO2009003199
SEARCHWO2010075266
SEARCHWO2010075327

Non-Patent Literature (NPL) Citations (14) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "DESMOPRESSIN Kyowa nasal spray 2.5µg spray dose", Kyowa, (20081001), pages 1 - 9, Kyowa, XP055598916
OPPOSITION- Anonymous, "Highlights of prescribing information - Noctiva - Reference ID: 4064231", US Food and Drug Administration, (20170301), XP055471878
OPPOSITION- "Chapter 4: Atomizers", Lefebvre Arthur H., Atomization and Sprays, Hemisphere Publishing Corp., (19890101), pages 105 - 127, XP055800935
OPPOSITION- DAY, N., "Aqueous Nasal Dosage Forms", Pharmaceutical, Preformulation and Formulation, (20090000), pages 456 - 474, XP055471909
OPPOSITION- LANSLEY, A.B. et al., "Nasal Drug Delivery", Drug Delivery and Targeting, (20010000), pages 215 - 243, XP055471862
OPPOSITION- "Liquid Dosage Forms", Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, (20050000), pages 404 - 408; 563, XP055800943
OPPOSITION- MALMSTEN, M. et al., "Microremulsions in Pharmaceuticals", Handbook of Microemulsion Science and Technology, (19990000), pages 755 - 770, XP055471899
OPPOSITION- MARX, D., "A Proactive Approach to Developing the Cartridge Pump System (CPS) in a Pressurized Market Environment", Drug Delivery Techn., (20090700), vol. 9, pages 28 , 30 - 33, XP055471896
OPPOSITION- MARX, D., "CPS nasal, New generation of nasal spray systems", Presentation given the Annual International Conference of Nasal Drug Delivery, London, UK (Marx, (20090402), XP055471887
OPPOSITION- STOTE, R.W. et al., "Intranasal Insulin - A Potential New Treatment Modality for Diabetes Mellitus", Drug Development Delivery, (20071000), vol. 7, pages 86 - 90 , 92, XP055471881
OPPOSITION- Lisbeth Illum, "Nasal drug delivery: new developments and strategies", Drug Discovery Today, AMSTERDAM, NL, (20021223), vol. 7, doi:10.1016/S1359-6446(02)02529-1, ISSN 1359-6446, pages 1184 - 1189, XP055471864
OPPOSITION- SUMAN, J.D. et al., "Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition", Pharmaceutical Research, (20020106), vol. 19, doi:10.1023/A:1013643912335, XP002376388
OPPOSITION- SUMAN J D,ET AL, "Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition", Pharmaceutical Research, Springer New York LLC, US, US, (20020101), vol. 19, no. 1, doi:10.1023/A:1013643912335, ISSN 0724-8741, pages 1 - 6, XP002376388
OPPOSITION- MAKIDON, P.E. et al., "Characterization of Stability and Nasal Delivery Systems for Immunization with Nanoemulsion-Based Vaccines", JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, (20100000), vol. 23, doi:10.1089/jamp.2009.0766, pages 77 - 89, XP055114283

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents